Vascular actions of the calcium-regulating hormones
- PMID: 8588114
Vascular actions of the calcium-regulating hormones
Abstract
The vascular actions of the hormones that participate in the regulation of whole animal calcium (Ca2+) homeostasis and related factors are discussed. Parathyroid hormone (PTH) has vasodilator activity that is mediated by a specific cell membrane receptor coupled to adenylate cyclase and thus increases intracellular cAMP and lowers intracellular Ca2+. The peptide may also block voltage-sensitive Ca2+ channels. However, the general consensus is that PTH does not achieve sufficient levels in the serum to modulate vascular reactivity. Parathyroid hormone does, however, share a common receptor and N-terminal amino acid sequence homology with parathyroid hormone-related peptide (PTHrp), which has many of the properties of a locally acting vascular regulator. Exciting actions of the steroid hormone, 1,25(OH)2 vitamin D3, have recently been described which suggest that the hormone is a vascular smooth muscle-differentiating agent and promises to set the stage for learning about the long-term modulatory actions of other steroid hormones. Calcitonin has minimal vascular actions, and although CGRP is not classifiable as a Ca(2+)-regulating hormone, it is a potent vasodilator neurotransmitter. Finally, within the past 2 years there has been a ground swell of activity surrounding the existence of the extracellular Ca2+ receptor that senses changes in interstitial Ca2+. The response of the smooth muscle cell to extracellular Ca2+ is discussed in the context of this receptor.
Similar articles
-
Human parathyroid hormone fragment(1-34) and human [Ala25,26,27]parathyroid hormone fragment(1-34): their vascular and intracellular calcium regulating action in vascular smooth muscle cells.J Pharmacol Exp Ther. 1994 Jan;268(1):19-24. J Pharmacol Exp Ther. 1994. PMID: 8301557
-
Calcium-regulating hormones in hypertension: vascular actions.Am J Clin Nutr. 1991 Jul;54(1 Suppl):220S-226S. doi: 10.1093/ajcn/54.1.220S. Am J Clin Nutr. 1991. PMID: 2053566 Review.
-
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.Dan Med Bull. 2008 Nov;55(4):186-210. Dan Med Bull. 2008. PMID: 19232159 Review.
-
Renal mRNA of PTH-PTHrP receptor, [Ca2+]i and phosphaturic response to PTH in phosphate depletion.Miner Electrolyte Metab. 1997;23(1):48-57. Miner Electrolyte Metab. 1997. PMID: 9058370
-
Parathyroid hormone 7-84 induces hypocalcemia and inhibits the parathyroid hormone 1-84 secretory response to hypocalcemia in rats with intact parathyroid glands.J Am Soc Nephrol. 2006 Jul;17(7):1923-30. doi: 10.1681/ASN.2005101136. Epub 2006 May 17. J Am Soc Nephrol. 2006. PMID: 16707565
Cited by
-
Vitamin D: Actions for the new millennium.Indian J Clin Biochem. 2000 Aug;15(Suppl 1):158-68. doi: 10.1007/BF02867555. Indian J Clin Biochem. 2000. PMID: 23105279 Free PMC article.
-
Association between parathyroid hormone levels and the extensiveness of coronary artery disease.Anatol J Cardiol. 2016 Nov;16(11):839-843. doi: 10.14744/AnatolJCardiol.2016.6799. Epub 2016 Apr 25. Anatol J Cardiol. 2016. PMID: 27147401 Free PMC article.
-
Evaluation of left ventricular functions in patients with primary hyperparathyroidism: is there any effect of parathyroidectomy?Wien Klin Wochenschr. 2017 May;129(9-10):329-336. doi: 10.1007/s00508-017-1186-y. Epub 2017 Mar 17. Wien Klin Wochenschr. 2017. PMID: 28314925 Clinical Trial.
-
Treatment of refractory angina in patients not suitable for revascularization.Nat Rev Cardiol. 2014 Feb;11(2):78-95. doi: 10.1038/nrcardio.2013.200. Epub 2013 Dec 24. Nat Rev Cardiol. 2014. PMID: 24366073 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Research Materials
Miscellaneous